Distribution of adipose-derived stem cells in adipose tissues from human cadavers
ABSTRACT Adipose-derived stem cells (ASCs) possess multipotency in vivo and in vitro, and thus are thought to be very promising precursors for use in regenerative medicine. ASCs can be concentrated from adipose tissue by enzymatic digestion and transplanted to increase angiogenesis or for cosmesis. ASC transplants are now being performed in a clinical setting. Although data on ASCs are extensive, the distribution of ASCs in human fat tissue has not been fully clarified. Thus, it is important to identify the distribution of ASCs to obtain cell populations rich in ASCs for clinical use.
ASCs express CD34, a cell surface marker. As CD34 is also expressed by endothelial cells, we immunohistochemically stained 2-μm-thick serial paraffin sections of fat tissue obtained from various parts of formalin-fixed cadavers with anti-CD31 and anti-CD34 antibodies to distinguish ASCs from endothelial cells.
CD34(+)/CD31(-) cells were mainly found in connective tissue tracts and perivascularly. Among fat tissues obtained from various sites, fat tissues in the thoracic back and lower abdomen were richest in CD34(+)/CD31(-) cells.
The concentrations of CD34(+)/CD31(-) cells in adipose tissues differ between sites. The sites most highly enriched for ASCs were identified, and it is now possible to select the best sites for collection of ASCs for transplantation.
SourceAvailable from: Paolo Cinelli[Show abstract] [Hide abstract]
ABSTRACT: Adipose-derived stem cells are easily accessed and have a relatively high density compared with other mesenchymal stromal cells. Isolation protocols of adipose-derived stem cells (ASC) rely on the cell's ability to adhere to tissue culture plastic overnight. It was evaluated whether the floating ASC fractions are also of interest for cell-based therapies. In addition, the impact of age, body mass index (BMI) and harvest site was assessed. The surface protein profile with the use of flow cytometry, the cell yield and the doubling time of passages 4, 5 and 6 of ASC from 30 donors were determined. Adherent and supernatant fractions were compared. The impact of age, BMI and harvest site on cell yield and doubling times was determined. Both adherent and supernatant fractions showed high mean fluorescence intensities for CD13, CD29, CD44, CD73, CD90 and CD105 and comparatively low mean fluorescence intensities for CD11b, CD62L, intracellular adhesion molecule-1 and CD34. Doubling times of adherent and supernatant fractions did not differ significantly. Whereas the old age group had a significantly lower cell yield compared with the middle aged group, BMI and harvest site had no impact on cell yield. Finally, doubling times for passages 4, 5 and 6 were not influenced by the age and BMI of the donors, nor the tissue-harvesting site. The floating ASC fraction is an equivalent second cell source just like the adherent ASC fraction. Donor age, BMI and harvest site do not influence cell yield and proliferation rate.Cytotherapy 06/2013; DOI:10.1016/j.jcyt.2013.04.009 · 3.10 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: PURPOSE: This randomized, controlled animal study investigated the morphological and histological properties of rabbit orbital fat following injection of human orbital adipose-derived stem cells (hoADSCs). METHODS: The efficacy of hoADSCs was compared with that of hyaluronic acid gel (HAG) and human orbital stromal vascular fraction (hoSVF). Thirty orbits from 15 New Zealand white rabbits (25 weeks postnatal, 2500-3000 g) were injected with HAG (MW 1,000,000, 0.5 ml) (n = 10), hoSVF (0.25 ml) mixed with HAG (0.25 ml) (n = 10), or hoADSCs (0.25 ml) mixed with HAG (0.25 ml) (n = 10). The degree of proptosis and the time course of changes were determined and compared among groups. RESULTS: The difference between the initial value exophthalmometric value and that at 4 weeks after injection was 1.77 mm for HAG and 2.01 mm for hoSVF. The difference between the initial value and that at 12 weeks decreased to 0.05 mm for HAG and 0.24 mm for hoSVF. In contrast, injection of hoADSCs increased the exophthalmometric value by 2.43 mm at 4 weeks after injection, and this difference was maintained at 2.56 mm at 12 weeks. Histopathological examination revealed specific inflammation around the injection materials at 4 weeks after injection, and inflammation subsided 8 weeks after injection in all three groups. CONCLUSIONS: Thus, transplantation of hoADSCs with HAG is a safe and effective technique for orbital fat volume expansion. This is a new and promising method for orbital reconstruction and aesthetic orbital volume augmentation.Investigative ophthalmology & visual science 03/2013; 54(4). DOI:10.1167/iovs.12-11210 · 3.66 Impact Factor
International Journal of Morphology 03/2013; 31(1):64-69. DOI:10.4067/S0717-95022013000100009 · 0.20 Impact Factor